Page last updated: 2024-08-22

zinc sulfate and Autosomal Dominant Cerebellar Ataxia, Type II

zinc sulfate has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aguilera-Rodríguez, R; Almaguer Mederos, LE; Batista, IH; Canales-Ochoa, N; García-Rodríguez, JC; Gotay, DA; Laffita Mesa, JM; López-Hernandez, OD; Novas, AJ; Polanco, ID; Porto-Verdecia, M; Pupo, NR; Rodríguez-Chanfrau, J; Rodríguez-Díaz, JC; Rodríguez-Labrada, R; Sánchez-Cruz, G; Triana, CG; Velázquez-Pérez, L1

Trials

1 trial(s) available for zinc sulfate and Autosomal Dominant Cerebellar Ataxia, Type II

ArticleYear
Oral zinc sulphate supplementation for six months in SCA2 patients: a randomized, double-blind, placebo-controlled trial.
    Neurochemical research, 2011, Volume: 36, Issue:10

    Topics: Adolescent; Adult; Catalase; Cuba; Dietary Supplements; Double-Blind Method; Humans; Malondialdehyde; Middle Aged; Placebos; Saccades; Spinocerebellar Ataxias; Superoxide Dismutase; Treatment Outcome; Young Adult; Zinc; Zinc Sulfate

2011